Cite
SAFETY AND EFFICACY OF DDP4-INHIBITORS FOR MANAGEMENT OF HOSPITALIZED GENERAL MEDICINE AND SURGERY PATIENTS WITH TYPE 2 DIABETES
MLA
Georgia Davis, et al. “Safety and Efficacy of Ddp4-Inhibitors for Management of Hospitalized General Medicine and Surgery Patients with Type 2 Diabetes.” Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists, Apr. 2020. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....42ee4dc28b5dfcfd3f15072e84f7431d&authtype=sso&custid=ns315887.
APA
Georgia Davis, Francisco J. Pasquel, David Reyes-Umpierrez, Priyathama Vellanki, Elena Atienza-Sánchez, Limin Peng, Cristina Lorenzo-González, Maya Fayfman, Saumeth Cardona, & Guillermo E. Umpierrez. (2020). Safety and Efficacy of Ddp4-Inhibitors for Management of Hospitalized General Medicine and Surgery Patients with Type 2 Diabetes. Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.
Chicago
Georgia Davis, Francisco J. Pasquel, David Reyes-Umpierrez, Priyathama Vellanki, Elena Atienza-Sánchez, Limin Peng, Cristina Lorenzo-González, Maya Fayfman, Saumeth Cardona, and Guillermo E. Umpierrez. 2020. “Safety and Efficacy of Ddp4-Inhibitors for Management of Hospitalized General Medicine and Surgery Patients with Type 2 Diabetes.” Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists, April. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....42ee4dc28b5dfcfd3f15072e84f7431d&authtype=sso&custid=ns315887.